Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: Abdullah Al-Ajmi, PharmD Candidate, Skaggs School of Pharmacy and Pharmaceutical Sciences Alexis Dunn, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences Lawand Kamal, PharmD Candidate 2021, Skaggs School of Pharmacy and Pharmaceutical Sciences Arjay Mendoza, PharmD Candidate, University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences Anina Pham, PharmD. Candidate, Lake Erie College of Osteopathic Medicine, College of Pharmacy Shadrielle Robbins, PharmD Candidate, South College School of Pharmacy | 
If nothing else has come out of the Corona crisis, there was a lot of conversation on the repurposing of older medications to try to reduce the effects or prevent COVID-19 infection. For a while there was some “exciting” research on the use of metformin to reduce the severity. However, like a lot of medications in the end it was not the panacea that the first comments would have led us to believe. 